#USA #AI Technology #Somerville #Matterworks #PyxisLabs

Introduction to PyxisLabs

In a remarkable stride towards advancing biochemical analysis, Matterworks has officially launched PyxisLabs™, an innovative AI Native Laboratory aimed at commercializing biochemical omics. At a time when precision and speed in biological analysis are crucial, PyxisLabs promises to offer coverage and economics rivaling that of traditional sequencing methods.

The Foundation of LSMs

Matterworks has established itself as a pioneer in predictive biology, primarily through its development of LSMs (Layered Spectral Models). These foundational models facilitate the direct machine interpretation of data related to small molecules, lipids, peptides, and proteins. With more than 10 billion spectra analyzed across a myriad of biological contexts and molecules, the Matterworks LSM-3 can adeptly determine the structures and concentrations of biomolecules on a scale that includes both genomes and exposomes.

Empowering Life Sciences with AI

The driving force behind PyxisLabs is the Matterworks Pyxis™, which acts as a co-scientist, making advanced biochemical interpretation accessible to researchers in the life sciences sector. The analysis capabilities provided by Pyxis have been rigorously validated against real-world benchmarks. Early adopters from various fields, including biopharma, health science, diagnostics, synthetic biology, and contract research, have benefited from these capabilities, showcasing the system’s robust application.

Jack M. Geremia, Ph.D., CEO and Co-Founder of Matterworks, articulated the vision for the company: "At Matterworks, we envision a future where biology is foreseeable, not empirical." He emphasized that Pyxis is set to unveil this future by delivering the biochemical layer essential for interpreting biological outcomes, thereby creating interconnected pathways that link diverse biological layers.

Dual Options for Organizations

Organizations interested in utilizing PyxisLabs have two flexible options:

1. License Pyxis: Users can license Pyxis for end-to-end interpretation of the data generated from their high-resolution LC-MS instruments.
2. Sample Submission: Alternatively, companies can send samples to PyxisLabs for de novo chemotyping and interpretation at a genome scale.

Currently, PyxisLabs offers services for small molecules and lipid chemotyping, with plans to expand into peptides and proteins in forthcoming announcements.

Bridging the Gap in Biochemical Analysis

This initiative bridges a significant gap in access to quantitative untargeted biochemical omics for application scientists and analytical chemists. With the same coverage, speed, and cost that facilitated the scalability of sequencing technologies, Pyxis is poised to revolutionize how scientists approach biochemical data. As Fadi Abdi, Ph.D., Executive Vice President and Head of PyxisLabs, noted, scientists can now resolve 'dark matter' and quantify biological abundance at concentrations necessary for revealing the mechanisms behind biological processes and discovering novel biological phenomena.

About PyxisLabs

PyxisLabs’ creation emphasizes the commercialization of scalable biochemical omics and advanced predictive biology. Leveraging the capabilities of Pyxis, the laboratory enables organizations to interpret omic data effectively, significantly elevating the quality and accessibility of biochemical analysis for researchers and industries alike.

Organizations can choose either to utilize their existing instruments or leverage PyxisLabs’ services to enhance their operational efficiencies.

About Matterworks

Founded and based in Somerville, Massachusetts, Matterworks stands at the forefront of AI-driven technologies in the biological sciences sector, transforming conventional methods from empirical approaches to ones that are foreseeable. The company has made substantial investments to curate the largest expert-labeled training dataset in the industry for PhD-level machine interpretation of biochemical and multi-omic data. The launch of Pyxis reflects its commitment to making advanced scientific expertise readily available to researchers across biological science fields, significantly impacting research and development within the industry.

In conclusion, PyxisLabs offers a groundbreaking approach to biochemical analysis, helping scientists unlock the complexities of biological data, paving the way for new discoveries and innovations in life sciences.